Mascoma Wealth Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $36.1K | Sell |
523
-200
| -28% | -$13.8K | 0.01% | 217 |
|
2025
Q1 | $49K | Hold |
723
| – | – | 0.01% | 190 |
|
2024
Q4 | $32.5K | Sell |
723
-667
| -48% | -$29.9K | 0.01% | 236 |
|
2024
Q3 | $87.4K | Hold |
1,390
| – | – | 0.02% | 150 |
|
2024
Q2 | $82.1K | Sell |
1,390
-100
| -7% | -$5.91K | 0.02% | 151 |
|
2024
Q1 | $119K | Hold |
1,490
| – | – | 0.03% | 125 |
|
2023
Q4 | $118K | Sell |
1,490
-35
| -2% | -$2.76K | 0.04% | 127 |
|
2023
Q3 | $106K | Buy |
1,525
+35
| +2% | +$2.44K | 0.03% | 132 |
|
2023
Q2 | $110K | Sell |
1,490
-33
| -2% | -$2.44K | 0.03% | 131 |
|
2023
Q1 | $112K | Sell |
1,523
-221
| -13% | -$16.2K | 0.03% | 158 |
|
2022
Q4 | $163K | Hold |
1,744
| – | – | 0.05% | 126 |
|
2022
Q3 | $166K | Hold |
1,744
| – | – | 0.06% | 123 |
|
2022
Q2 | $162K | Sell |
1,744
-75
| -4% | -$6.97K | 0.06% | 125 |
|
2022
Q1 | $184K | Buy |
1,819
+46
| +3% | +$4.65K | 0.06% | 127 |
|
2021
Q4 | $183K | Buy |
1,773
+5
| +0.3% | +$516 | 0.06% | 112 |
|
2021
Q3 | $150K | Buy |
+1,768
| New | +$150K | 0.06% | 121 |
|
2021
Q2 | – | Sell |
-1,735
| Closed | -$131K | – | 176 |
|
2021
Q1 | $131K | Buy |
+1,735
| New | +$131K | 0.06% | 130 |
|
2019
Q3 | – | Sell |
-271
| Closed | -$15K | – | 133 |
|
2019
Q2 | $15K | Sell |
271
-12
| -4% | -$664 | 0.01% | 242 |
|
2019
Q1 | $15K | Sell |
283
-40
| -12% | -$2.12K | 0.01% | 242 |
|
2018
Q4 | $21K | Buy |
323
+48
| +17% | +$3.12K | 0.02% | 207 |
|
2018
Q3 | $22K | Hold |
275
| – | – | 0.01% | 227 |
|
2018
Q2 | $18K | Sell |
275
-195
| -41% | -$12.8K | 0.01% | 228 |
|
2018
Q1 | $29K | Hold |
470
| – | – | 0.02% | 191 |
|
2017
Q4 | $36K | Buy |
470
+40
| +9% | +$3.06K | 0.02% | 164 |
|
2017
Q3 | $35K | Hold |
430
| – | – | 0.02% | 174 |
|
2017
Q2 | $35K | Hold |
430
| – | – | 0.02% | 182 |
|
2017
Q1 | $34K | Sell |
430
-53
| -11% | -$4.19K | 0.02% | 172 |
|
2016
Q4 | $38K | Buy |
+483
| New | +$38K | 0.03% | 163 |
|